Bone Histomorphometry, Microarchitecture, and Matrix Structure in Postmenopausal (PMO) Women Receiving Long-term Alendronate or Risedronate.
Phase of Trial: Phase II
Latest Information Update: 21 Sep 2011
At a glance
- Drugs Alendronic acid; Risedronic acid
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Procter & Gamble
- 21 Sep 2011 Additional trial location Canada identified as reported by ClinicalTrials.gov.
- 15 Nov 2008 New trial record.